Preparedness and Response to Biological Emergencies

Why It Matters

Without a robust, funded biodefense framework, the United States faces heightened security, economic, and health risks from emerging biological threats.

Key Takeaways

• US biodefense funding has never been fully authorized by Congress
• Budget cuts since 2025 have eroded national bio‑incident preparedness
• Supply‑chain weaknesses jeopardize critical medical countermeasure production in the United States
• Withdrawal from global partnerships hampers coordinated response to international outbreaks
• Legislative clarity and diversified supply chains can restore surge capacity

Summary

The video outlines the United States’ chronic shortfall in a comprehensive, fully funded biodefense program, noting that every administration since 1996 has issued plans that Congress never fully financed. It warns that by 2025, deep cuts to civilian and military budgets have further eroded the nation’s capacity to detect, prevent, and respond to biological emergencies, endangering public health and national security.

Key insights include persistent underinvestment in federal, state, and local programs, supply‑chain shortages of critical medical products, and a loss of leadership in biotech domains to China. The speaker also highlights the strategic risk of withdrawing from international partnerships, which would impede coordinated responses to global outbreaks.

The presenter calls for clear congressional delineation of responsibilities among government, academia, and private sectors, alongside incentives for better coordination. He advocates diversified supply chains for tests, treatments, vaccines, and PPE, sustained funding for public health and veterinary infrastructure, and flexible hiring and reserve funding to ensure surge capacity during crises.

If enacted, these actions could safeguard national security, preserve economic prosperity, and maintain U.S. competitiveness in biotechnology innovation, turning a fragmented biodefense landscape into a resilient, rapid‑response system.

Original Description

Michaela Simoneau explains why the United States faces gaps in its response to bioincidents, how those vulnerabilities endanger American security and competitiveness, and how to strengthen routine and emergency health services to better prepare for future threats.

---------------------------------------------

A nonpartisan institution, CSIS is the top national security think tank in the world.

Visit https://www.csis.org to find more of our work as we bring bipartisan solutions to the world's greatest challenges.

Want to see more videos and virtual events? Subscribe to this channel and turn on notifications: https://cs.is/2dCfTve

Follow CSIS on:

• Twitter: https://twitter.com/csis

• Facebook: https://facebook.com/CSIS.org

• Instagram: https://instagram.com/csis/